Regulation (EC) No 1901/2006 on medicinal products for paediatric use & clinical research in vulnerable populations
<p>Abstract</p> <p>Before any medicinal product is authorised for use in adults, it must undergo extensive pharmaceutical consistency and stability tests, toxicological tests and clinical trials to ensure that it is of high quality, safe and effective.</p> <p>The same a...
Main Author: | Lehmann Birka |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-12-01
|
Series: | Child and Adolescent Psychiatry and Mental Health |
Online Access: | http://www.capmh.com/content/2/1/37 |
Similar Items
-
Paediatric Medicines in Europe: The Paediatric Regulation—Is It Time for Reform?
by: Maddalena Toma, et al.
Published: (2021-02-01) -
Education in Afghanistan, 1901-2006 : Developments, influences and legacies
by: Baiza, Yahia
Published: (2010) -
Vulnerabilities in Security Products for Computers 2006-2008
by: Liaqat, Imran
Published: (2009) -
A review of decision-making in the Authorisation regime of Regulation (EC) 1907/2006 REACH
by: Forkman, Mats
Published: (2019) -
Evaluation of groundwater monitoring according to 2000/60/EC and 2006/118/EC directives in Piedmont
by: Riccardo Balsotti, et al.
Published: (2013-09-01)